Trial Profile
Randomized, Open-label, Multi-centered Study to Evaluate the Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia(Phase 4)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hypercholesterolaemia; Prediabetic state
- Focus Therapeutic Use
- Acronyms SIPHON
- Sponsors JW Pharmaceutical
- 10 Sep 2020 Primary endpoint (The change of HbA1c before and after taking LIVALO) has not been met according to the results published in the Clinical Therapeutics
- 10 Sep 2020 Results published in the Clinical Therapeutics
- 06 Mar 2018 Status changed from active, no longer recruiting to completed.